Allworth Financial LP

Position in CLLS — Cellectis S.A.

CIK 1555170 FOLSOM, CA

Position in CLLS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,585

-$1,580 QoQ

Shares Held

500

-23.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Allworth Financial LP holds $21,498,679 across 297 Biotechnology names. CLLS ranks #197 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	15,803	$7,056,671
2	HALO	Halozyme Therapeutics, Inc.	36,244	$2,342,449
3	REGN	Regeneron Pharmaceuticals, Inc.	2,991	$2,310,966
4	MDGL	Madrigal Pharmaceuticals, Inc.	3,562	$1,864,600
5	CPRX	Catalyst Pharmaceuticals, Inc.	26,462	$655,199
6	CRSP	CRISPR Therapeutics AG	11,016	$524,031
7	INCY	Incyte Corp	4,834	$454,976
8	EXEL	Exelixis, Inc.	10,084	$432,502

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,585	500	-23.5%	Shares	Sole	2026-05-15
2025-12-31	$3,165	654	+30.8%	Shares	Sole	2026-02-05
2025-09-30	$1,425	500	0.0%	Shares	Sole	2025-12-02
2025-06-30	$762	500	-68.8%	Shares	Sole	2025-08-07
2025-03-31	$1,984	1,600	+220.0%	Shares	Sole	2025-04-30
2024-12-31	$900	500	0.0%	Shares	Sole	2025-01-30
2024-09-30	$1,060	500	0.0%	Shares	Sole	2024-10-23
2024-06-30	$935	500	0.0%	Shares	Sole	2024-07-24
2024-03-31	$1,325	500	0.0%	Shares	Sole	2024-04-25
2023-12-31	$1,540	500	+7042.9%	Shares	Sole	2024-01-24
2020-12-31	$189	7	—	Shares	Sole	2021-01-26
No filing history on record for this holder in this stock.